Cara Haymaker

Cara Haymaker

UNVERIFIED PROFILE

Are you Cara Haymaker?   Register this Author

Register author
Cara Haymaker

Cara Haymaker

Publications by authors named "Cara Haymaker"

Are you Cara Haymaker?   Register this Author

48Publications

1640Reads

21Profile Views

TIL therapy and anti-CTLA4: can they co-exist?

Oncotarget 2019 Jan 1;10(1):1-2. Epub 2019 Jan 1.

Chantale Bernatchez: Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, USA; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/26509
Publisher Site
http://dx.doi.org/10.18632/oncotarget.26509DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343756PMC
January 2019

Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in -Mutant Melanoma.

JCO Precis Oncol 2018 5;2018. Epub 2018 Jun 5.

Junna Oba, Sun-Hee Kim, Wei-Lien Wang, Mariana P. Macedo, Fernando Carapeto, Meredith A McKean, John Van Arnam, Agda K. Eterovic, Shiraj Sen, Charuta R. Kale, Xiaoxing Yu, Cara L. Haymaker, Mark Routbort, Lauren E. Haydu, Chantale Bernatchez, Alexander J. Lazar, Elizabeth A. Grimm, David S. Hong, and Scott E. Woodman, The University of Texas MD Anderson Cancer Center, Houston, TX; and Mariana P. Macedo, AC Camargo Cancer Center, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080631PMC
http://dx.doi.org/10.1200/PO.18.00055DOI Listing
June 2018

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model.

J Vis Exp 2017 11 28(129). Epub 2017 Nov 28.

Department of Immunology, University of Texas MD Anderson Cancer Center;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/56255DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755481PMC
November 2017

Immune-Modulation by Epidermal Growth Factor Receptor Inhibitors: Implication on Anti-Tumor Immunity in Lung Cancer.

PLoS One 2016 28;11(7):e0160004. Epub 2016 Jul 28.

Division of Oncology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0160004PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965069PMC
August 2017

Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanoma.

J Immunother 2014 Nov-Dec;37(9):448-60

*Department of Melanoma Medical Oncology †Division of Pediatrics, MD Anderson Cancer Center, Houston, TX ‡Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center and trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, MD ∥Lion Biotechnologies, Woodland Hills, CA §Sidra Medical and Research Hospital, Doha, Qatar.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199393PMC
November 2015

BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties.

Oncoimmunology 2015 Aug 16;4(8):e1014246. Epub 2015 Mar 16.

Department of Melanoma Medical Oncology; The University of Texas MD Anderson Cancer Center ; Houston, TX USA ; Lion Biotechnologies ; Tampa, FL USA ; Department of Immunology; H Lee Moffitt Cancer Center ; Tampa, FL USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1014246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570103PMC
August 2015

Tumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical development.

BioDrugs 2014 Oct;28(5):421-37

Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Box 904, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40259-014-0097-yDOI Listing
October 2014

PD-1 and BTLA and CD8(+) T-cell "exhaustion" in cancer: "Exercising" an alternative viewpoint.

Oncoimmunology 2012 Aug;1(5):735-738

Department of Melanoma Medical Oncology; University of Texas; MD Anderson Cancer Center; Houston, TX USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.20823DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429577PMC
August 2012

APCs expressing high levels of programmed death ligand 2 sustain the development of CD4 T cell memory.

J Immunol 2010 Sep 13;185(6):3149-57. Epub 2010 Aug 13.

Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia, MO 65212, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1000810DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057906PMC
September 2010

FoxP3+RORgammat+ T helper intermediates display suppressive function against autoimmune diabetes.

J Immunol 2010 Apr 24;184(7):3377-85. Epub 2010 Feb 24.

Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia, MO 65212, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.0903324DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843758PMC
April 2010

Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity.

J Exp Med 2008 Sep 1;205(10):2269-80. Epub 2008 Sep 1.

Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia, MO 65212, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20071371DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556775PMC
September 2008

In trans T cell tolerance diminishes autoantibody responses and exacerbates experimental allergic encephalomyelitis.

J Immunol 2008 Feb;180(3):1508-16

Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO 65212, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.180.3.1508DOI Listing
February 2008